Genotype-dependent behavioral signatures of opioid withdrawal revealed by automated behavioral quantification
Opioid withdrawal drives continued opioid use in opioid use disorder (OUD), which affected an estimated 4 million Americans in 2024. However, only one non-opioid medication is FDA-approved for withdrawal treatment, and there is great need for more diverse treatment options. Mice are powerful models to study opioid withdrawal because they allow for controlled drug and environmental exposure,…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
